BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

26.67B

Market cap26.67B

Price-Earnings ratio

-70.01

Price-Earnings ratio-70.01

Dividend yield

—

Dividend yield—

Average volume

565.27K

Average volume565.27K

High today

$112.90

High today$112.90

Low today

$110.75

Low today$110.75

Open price

$110.75

Open price$110.75

Volume

392.58K

Volume392.58K

52 Week high

$131.49

52 Week high$131.49

52 Week low

$81.20

52 Week low$81.20

BNTX News

TipRanks 3d

BioNTech SE’s New Study: A Potential Game-Changer in Pancreatic Cancer Treatment?

Biontech SE (($CC:BNTX.CUR)), Biontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take adva...

Analyst ratings

71%

of 24 ratings

Buy

70.8%

Hold

29.2%

Sell